<DOC>
	<DOCNO>NCT01627158</DOCNO>
	<brief_summary>The purpose study compare test product Budesonide/formoterol Easyhaler market product Symbicort Turbuhaler term drug absorb bloodstream .</brief_summary>
	<brief_title>Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler Symbicort Turbuhaler Forte</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Charcoal</mesh_term>
	<criteria>1 . Written informed consent ( IC ) obtain . 2 . Males female , 1860 ( inclusive ) year age . 1 . Evidence clinically significant cardiovascular , renal , hepatic , haematological , GI , pulmonary , metabolicendocrine , neurological psychiatric disease . 2 . Any clinically significant abnormal laboratory value physical finding may interfere interpretation study result constitute health risk subject he/she take part study . 3 . Any condition require regular concomitant treatment ( include vitamin herbal product ) likely need concomitant treatment study . 4 . Known hypersensitivity active substance ( ) excipient drug . 5 . Pregnant lactating female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>